Continuing our series of updates on our new website we’re highlighting our Life Sciences section. In this section, you'll find our focus markets, including Endoscopy, Diagnostics, Robot-Assisted Surgery, Cardiovascular Therapies, Oncology, and Pharmaceuticals. We invite you to check out our Life Sciences page and learn more about how our cutting-edge technologies can support your needs. Let us know what you think and reach out for more information! Visit Now! https://lnkd.in/dnniKPGf #ElosMedtech #LifeScience #CDMO #MedicalDevices
Elos Medtech’s Post
More Relevant Posts
-
Ondansetron is used to prevent nausea and vomiting caused by cancer chemotherapy, radiation therapy, and surgery. Ondansetron is in a class of medications called serotonin 5-HT3 receptor antagonists. Stay tuned with us every Friday for more such cool facts. Design credit: Ali Haider Content credit: Ali Haider #nfpsdelhi #pharmafacts #facttalks #facts #factz #pharmacyfacts #everyfriday #pharmacists #pharmacyindustry #pharmaMadeEasy #pharmaceuticals #factoftheday
To view or add a comment, sign in
-
Clinical trials are research studies that help us improve diagnostic tests and treatment options. Our clinical trials program enrolls client-owned pets to evaluate the effectiveness of new drugs, find novel uses of old drugs, or investigate new approaches to surgery and/or radiation therapy to treat cancer. Many of the standard treatments used today are the result of clinical trials. We learn valuable information from every patient, and we use this information to improve their care as well as the care of future patients, both pets and people. Clinical trials are one of the biggest ways we can fight cancer. Learn more: https://buff.ly/3IVvbtf
To view or add a comment, sign in
-
Traditionally, surgical oncologists and their patients have had to rely on 2D, black-and-white images, seen through the eyes of a radiologist. But with Avatar Medical, this changes dramatically. Surgeons and patients can now see tumors in stunning 3D, alongside vessels, soft tissue, and bone, making it easier to assess the best treatment options and anticipate risks. Curious to learn more about how Avatar Medical is transforming the field of surgical oncology? Visit https://lnkd.in/gvVZsdjd #MedicalInnovation #3DImaging #MixedReality #HealthcareTech #SurgicalOncology
To view or add a comment, sign in
-
So excited to announce the most recent publications from I-SPY! The first 2 arms of our new patient-centered trial, I-SPY 2.2, designed to personalize treatment to tumor type and response, were published on Sept 14th. The results were also presented at European Society of Medical Oncology. From the first to last patient accrued it took 2 years, including the completion of therapy and surgical results to presentation! This is a huge milestone. Accelerating the pace at which we generate new knowledge is the key- that is the Mission of the I SPY Program, our academic consortium, and QuantumLeap Healthcare Collaborative. That is how we will get the right drug to the right patient at the right time. The goal of I SPY 2.2 is to get every patient to complete pathological response, meaning there is no tumor left when systemic treatment is started before surgery, and to decrease toxicity to patients. Read more about it here! https://lnkd.in/gaAZsmCi https://lnkd.in/g47KpDkC
To view or add a comment, sign in
-
Esophageal cancer treatment is personalized based on cancer type, stage, overall health, and patient preferences. Surgery may be recommended, ranging from removing small tumors to extensive procedures like esophagectomy or esophagogastrectomy. Tailored treatment plans offer hope for improved outcomes. Additional treatment options include: ☑️Chemotherapy ☑️Radiation therapy ☑️Combined chemotherapy and radiation ☑️Targeted drug therap ☑️Immunotherapy #EsophagealCancerTreatment #PersonalizedCare
To view or add a comment, sign in
-
Stay on top of the latest developments in care with Spotlight On Hepatocellular Carcinoma. Designed for oncologists, gastroenterologists, hepatologists, surgeons, and other healthcare professionals involved in managing hepatocellular carcinoma, this collection of curated programs covers current and emerging diagnostic techniques, conventional treatments, novel therapeutic approaches, and more. Enhance your practice and stay informed about the latest advancements in hepatocellular carcinoma care. Gain insights on treatment: https://ow.ly/Coxu50SL2wW #HepatocellularCarcinoma #Oncology #Gastroenterology #Hepatology #Surgery #MedicalResearch #HealthcareProfessionals #CancerCare
To view or add a comment, sign in
-
#Prostate_Cancer_Minimally_Invasive_Surgery Market Estimated to Expand at a Robust CAGR over 2023–2032 https://bit.ly/3wTm2Kz #Prostate cancer minimally invasive #surgery is a type of surgery that is used to #treat prostate #cancer. It is a safe and effective #option for treating prostate #cancer, offering a faster #recovery time, lower risk of #complications and better #preservation of #sexual and urinary #function. AngioDynamics B. Braun Group Becton Dickenson Dickinson Group of Companies Ethicon Endo-Surgery, Inc. Intuitive Surgical Ltd Medtronic Olympus Corporation Siemens Healthcare Pvt. Ltd. #marketresearch #healthcare #technologies #prostatecancer #pharmaceuticals #healthcareindustry
To view or add a comment, sign in
-
#Prostate_Cancer_Minimally_Invasive_Surgery Market Estimated to Expand at a Robust CAGR over 2023–2032 https://bit.ly/3wTm2Kz #Prostate cancer minimally invasive #surgery is a type of surgery that is used to #treat prostate #cancer. It is a safe and effective #option for treating prostate #cancer, offering a faster #recovery time, lower risk of #complications and better #preservation of #sexual and urinary #function. AngioDynamics B. Braun Group Becton Dickenson Dickinson Group of Companies Ethicon Endo-Surgery, Inc. Intuitive Surgical Ltd Medtronic Olympus Corporation Siemens Healthcare Pvt. Ltd. #marketresearch #healthcare #technologies #prostatecancer #pharmaceuticals #healthcareindustry
To view or add a comment, sign in
-
Alternative Treatments for eBC and mBC: Key opinion leaders (KOLs) discuss the use of CDK4/6 inhibitors in early breast cancer, specifically in patients who have undergone chemotherapy and surgery. They highlight the key factors that help determine which patients are most likely to benefit from receiving these medications. #finance #pharmacy #lifesciences
Alternative Treatments for eBC and mBC
pharmacytimes.com
To view or add a comment, sign in
-
Desmoid tumors, though benign, can pose significant challenges due to their unpredictable growth and recurrence. Traditional treatments like surgery and radiation have limitations, but recent advancements in targeted therapies such as Tyrosine Kinase Inhibitors (TKIs) and Gamma-Secretase Inhibitors offer promising alternatives. These emerging strategies and watchful waiting for indolent cases reshape the treatment landscape. As research continues, personalized approaches will become essential in managing this complex condition. Explore the latest developments in desmoid tumor treatment and the future of innovative care. https://lnkd.in/dCrZMq9r #DesmoidTumors #HealthcareInnovation #TargetedTherapies #MedicalResearch #ClinicalTrials #TumorTreatment #OncologyCare #PrecisionMedicine #Immunotherapy #MedicalAdvancements Ajay Gupta
To view or add a comment, sign in
7,801 followers